Bill
SD 891
Creates medical exemption allowing pharmaceutical manufacturers to distribute patient coupons for prescription drugs, potentially reducing patient costs but raising anti-kickback and cost-shifting concerns.
SD 891 would establish a medical exemption allowing manufacturers to distribute coupons for prescription medications without triggering anti-kickback restrictions. The bill creates a carve-out from existing regulations that prohibit pharmaceutical manufacturers from offering discounts directly to patients, permitting coupon programs under specified medical circumstances.
Prescription medication costs significantly burden patients, particularly those with chronic conditions requiring expensive drugs. This bill could lower out-of-pocket costs for certain medications, but it also touches on federal anti-kickback laws designed to prevent manufacturers from artificially inflating drug prices or steering patients toward particular treatments regardless of medical necessity.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
